From the Centers for Disease Control and Prevention. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000453:epidemiology / Q000209:etiology*; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D005845:Georgia; D006801:Humans; D008297:Male; D008875:Middle Aged; D009518:New York; D011718:Pyrazinamide / Q000009:adverse effects*; D012293:Rifampin / Q000009:adverse effects*; D014376:Tuberculosis / Q000188:drug therapy
D000995:Antitubercular Agents; D011718:Pyrazinamide; D012293:Rifampin